Preventive effect of pre-warming, hot compress, and pH adjustment in oxaliplatin-induced venous pain

Hitoshi Kawazoe, Satomi Sumikawa, Kana Nakauchi, Yoshihiro Yakushijin, Yuji Yamamoto, Yuji Watanabe, Akihiro Tanaka, Hiroaki Araki

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Background Venous pain induced by peripheral intravenous administration of oxaliplatin remains clinically unresolved. Objective The aim of this study was to determine the efficacy of comprehensive intervention care for venous pain in colorectal cancer patients receiving oxaliplatin. Setting A Japanese tertiary hospital. Method We treated all outpatients after April 2012 with comprehensive intervention care including pre-warming of the oxaliplatin solution, use of a hot compress, and pH adjustment by combination with dexamethasone. We retrospectively reviewed the electronic medical records from colorectal cancer patients who had received oxaliplatin via a peripheral vein between December 2009 and June 2014. Main outcome measures The primary endpoint of this study was the incidence of venous pain at the administration site during oxaliplatin infusion, according to injection site reaction grade ≥ 2. Results We evaluated 271 treatment courses in 59 patients. Venous pain occurred in 42 courses (15.5%) among 26 patients. Multivariate logistic regression analysis revealed that female gender and body mass index ≥ 25 kg/m2 were significantly associated with an increased risk of venous pain during all courses (adjusted odds ratio [OR]: 3.18, 95% confidence interval [CI] 1.35–7.92; P < 0.01; and adjusted OR: 3.37, 95% CI 1.26–9.40; P = 0.02, respectively), whereas comprehensive intervention care were significantly associated with reduced risk of venous pain during all courses (adjusted OR: 0.10, 95% CI 0.02–0.44; P < 0.01). Conclusion Comprehensive intervention care is a clinical treatment option for oxaliplatin-induced peripheral venous pain in patients with colorectal cancer, especially females with obesity.

Original languageEnglish
Pages (from-to)1291-1297
Number of pages7
JournalInternational Journal of Clinical Pharmacy
Volume39
Issue number6
DOIs
Publication statusPublished - 2017 Dec 1
Externally publishedYes

Fingerprint

oxaliplatin
Social Adjustment
Pain
Colorectal Neoplasms
Odds Ratio
Confidence Intervals
Electronic medical equipment
Electronic Health Records
Regression analysis
Dexamethasone
Logistics
Tertiary Care Centers
Intravenous Administration

Keywords

  • Dexamethasone
  • Hot compress
  • Oxaliplatin
  • Pre-warming
  • Venous pain

ASJC Scopus subject areas

  • Pharmacy
  • Toxicology
  • Pharmacology
  • Pharmaceutical Science
  • Pharmacology (medical)

Cite this

Preventive effect of pre-warming, hot compress, and pH adjustment in oxaliplatin-induced venous pain. / Kawazoe, Hitoshi; Sumikawa, Satomi; Nakauchi, Kana; Yakushijin, Yoshihiro; Yamamoto, Yuji; Watanabe, Yuji; Tanaka, Akihiro; Araki, Hiroaki.

In: International Journal of Clinical Pharmacy, Vol. 39, No. 6, 01.12.2017, p. 1291-1297.

Research output: Contribution to journalArticle

Kawazoe, H, Sumikawa, S, Nakauchi, K, Yakushijin, Y, Yamamoto, Y, Watanabe, Y, Tanaka, A & Araki, H 2017, 'Preventive effect of pre-warming, hot compress, and pH adjustment in oxaliplatin-induced venous pain', International Journal of Clinical Pharmacy, vol. 39, no. 6, pp. 1291-1297. https://doi.org/10.1007/s11096-017-0536-1
Kawazoe, Hitoshi ; Sumikawa, Satomi ; Nakauchi, Kana ; Yakushijin, Yoshihiro ; Yamamoto, Yuji ; Watanabe, Yuji ; Tanaka, Akihiro ; Araki, Hiroaki. / Preventive effect of pre-warming, hot compress, and pH adjustment in oxaliplatin-induced venous pain. In: International Journal of Clinical Pharmacy. 2017 ; Vol. 39, No. 6. pp. 1291-1297.
@article{21a43d0b1f11459aba7213000c5a79bc,
title = "Preventive effect of pre-warming, hot compress, and pH adjustment in oxaliplatin-induced venous pain",
abstract = "Background Venous pain induced by peripheral intravenous administration of oxaliplatin remains clinically unresolved. Objective The aim of this study was to determine the efficacy of comprehensive intervention care for venous pain in colorectal cancer patients receiving oxaliplatin. Setting A Japanese tertiary hospital. Method We treated all outpatients after April 2012 with comprehensive intervention care including pre-warming of the oxaliplatin solution, use of a hot compress, and pH adjustment by combination with dexamethasone. We retrospectively reviewed the electronic medical records from colorectal cancer patients who had received oxaliplatin via a peripheral vein between December 2009 and June 2014. Main outcome measures The primary endpoint of this study was the incidence of venous pain at the administration site during oxaliplatin infusion, according to injection site reaction grade ≥ 2. Results We evaluated 271 treatment courses in 59 patients. Venous pain occurred in 42 courses (15.5{\%}) among 26 patients. Multivariate logistic regression analysis revealed that female gender and body mass index ≥ 25 kg/m2 were significantly associated with an increased risk of venous pain during all courses (adjusted odds ratio [OR]: 3.18, 95{\%} confidence interval [CI] 1.35–7.92; P < 0.01; and adjusted OR: 3.37, 95{\%} CI 1.26–9.40; P = 0.02, respectively), whereas comprehensive intervention care were significantly associated with reduced risk of venous pain during all courses (adjusted OR: 0.10, 95{\%} CI 0.02–0.44; P < 0.01). Conclusion Comprehensive intervention care is a clinical treatment option for oxaliplatin-induced peripheral venous pain in patients with colorectal cancer, especially females with obesity.",
keywords = "Dexamethasone, Hot compress, Oxaliplatin, Pre-warming, Venous pain",
author = "Hitoshi Kawazoe and Satomi Sumikawa and Kana Nakauchi and Yoshihiro Yakushijin and Yuji Yamamoto and Yuji Watanabe and Akihiro Tanaka and Hiroaki Araki",
year = "2017",
month = "12",
day = "1",
doi = "10.1007/s11096-017-0536-1",
language = "English",
volume = "39",
pages = "1291--1297",
journal = "International Journal of Clinical Pharmacy",
issn = "2210-7703",
publisher = "Springer Netherlands",
number = "6",

}

TY - JOUR

T1 - Preventive effect of pre-warming, hot compress, and pH adjustment in oxaliplatin-induced venous pain

AU - Kawazoe, Hitoshi

AU - Sumikawa, Satomi

AU - Nakauchi, Kana

AU - Yakushijin, Yoshihiro

AU - Yamamoto, Yuji

AU - Watanabe, Yuji

AU - Tanaka, Akihiro

AU - Araki, Hiroaki

PY - 2017/12/1

Y1 - 2017/12/1

N2 - Background Venous pain induced by peripheral intravenous administration of oxaliplatin remains clinically unresolved. Objective The aim of this study was to determine the efficacy of comprehensive intervention care for venous pain in colorectal cancer patients receiving oxaliplatin. Setting A Japanese tertiary hospital. Method We treated all outpatients after April 2012 with comprehensive intervention care including pre-warming of the oxaliplatin solution, use of a hot compress, and pH adjustment by combination with dexamethasone. We retrospectively reviewed the electronic medical records from colorectal cancer patients who had received oxaliplatin via a peripheral vein between December 2009 and June 2014. Main outcome measures The primary endpoint of this study was the incidence of venous pain at the administration site during oxaliplatin infusion, according to injection site reaction grade ≥ 2. Results We evaluated 271 treatment courses in 59 patients. Venous pain occurred in 42 courses (15.5%) among 26 patients. Multivariate logistic regression analysis revealed that female gender and body mass index ≥ 25 kg/m2 were significantly associated with an increased risk of venous pain during all courses (adjusted odds ratio [OR]: 3.18, 95% confidence interval [CI] 1.35–7.92; P < 0.01; and adjusted OR: 3.37, 95% CI 1.26–9.40; P = 0.02, respectively), whereas comprehensive intervention care were significantly associated with reduced risk of venous pain during all courses (adjusted OR: 0.10, 95% CI 0.02–0.44; P < 0.01). Conclusion Comprehensive intervention care is a clinical treatment option for oxaliplatin-induced peripheral venous pain in patients with colorectal cancer, especially females with obesity.

AB - Background Venous pain induced by peripheral intravenous administration of oxaliplatin remains clinically unresolved. Objective The aim of this study was to determine the efficacy of comprehensive intervention care for venous pain in colorectal cancer patients receiving oxaliplatin. Setting A Japanese tertiary hospital. Method We treated all outpatients after April 2012 with comprehensive intervention care including pre-warming of the oxaliplatin solution, use of a hot compress, and pH adjustment by combination with dexamethasone. We retrospectively reviewed the electronic medical records from colorectal cancer patients who had received oxaliplatin via a peripheral vein between December 2009 and June 2014. Main outcome measures The primary endpoint of this study was the incidence of venous pain at the administration site during oxaliplatin infusion, according to injection site reaction grade ≥ 2. Results We evaluated 271 treatment courses in 59 patients. Venous pain occurred in 42 courses (15.5%) among 26 patients. Multivariate logistic regression analysis revealed that female gender and body mass index ≥ 25 kg/m2 were significantly associated with an increased risk of venous pain during all courses (adjusted odds ratio [OR]: 3.18, 95% confidence interval [CI] 1.35–7.92; P < 0.01; and adjusted OR: 3.37, 95% CI 1.26–9.40; P = 0.02, respectively), whereas comprehensive intervention care were significantly associated with reduced risk of venous pain during all courses (adjusted OR: 0.10, 95% CI 0.02–0.44; P < 0.01). Conclusion Comprehensive intervention care is a clinical treatment option for oxaliplatin-induced peripheral venous pain in patients with colorectal cancer, especially females with obesity.

KW - Dexamethasone

KW - Hot compress

KW - Oxaliplatin

KW - Pre-warming

KW - Venous pain

UR - http://www.scopus.com/inward/record.url?scp=85031415361&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85031415361&partnerID=8YFLogxK

U2 - 10.1007/s11096-017-0536-1

DO - 10.1007/s11096-017-0536-1

M3 - Article

C2 - 29027645

AN - SCOPUS:85031415361

VL - 39

SP - 1291

EP - 1297

JO - International Journal of Clinical Pharmacy

JF - International Journal of Clinical Pharmacy

SN - 2210-7703

IS - 6

ER -